Stelios Haji-Ioannou, founder of EasyJet, is set to launch a new airline to compete with his old company. The new airline will be called FastJet. Stelios sold controlling interest in the business ten years ago, and has been operating under a non-compete agreement with the new owners, but he claims that they have breached the agreement and so he's ready to go head to head with them.
I rather like EasyJet for providing a simple, bus-like shuttle around European cities. Generally, they provide superior service to their low-cost rivals RyanAir (I wouldn't fly RyanAir again even if it meant missing someone's funeral). And they've often shown innovative flourishes that I really appreciated -- for example, in Geneva, the EasyJet automatic check-in dispenses boarding-cards that are the same size as credit cards, so you can carry them in your wallet.
I'm inclined to think that whatever Stelios launches next will benefit from all the stuff he learned with EasyJet, and yet will be able to start afresh, avoiding whatever baggage EasyJet has to lug around as a result of its mistakes along the way. Certainly, Stelios seems to me to be someone who believes in a less humiliating, less uncomfortable, less stressful travel experience, and we could always use more of that.
One immediate difficulty Haji-Ioannou faces in launching a rival is that he continues to own 26% stake in easyJet, while family members have an 11% stake through a company called Polys Holdings.
The Haji-Ioannou family's combined holding was worth around £550m at Monday'sclosing share price. There were reports that other shareholders were calling for him to sell immediately.
It may not be easy, either, for Haji-Ioannou to achieve the success he had with easyJet when setting up a new airline.
(Image: Stelios Haji-Ioannou, CEO of easyGroup, a Creative Commons Attribution (2.0) image from 35952250@N02's photostream
Gabriella Corley is a 9 year old with Type I diabetes who’s allergic to the insulin covered by her low-income parents’ healthcare; to live, she must take Sanofi’s proprietary Apidra brand insulin, which has increased in price by 1,123% since 1996, and which is only covered to 25% by her insurer’s Pharmacy Benefit Manager, CVS.
Since the earliest days of ecommerce, analysts have predicted that retailers would use their estimations of their customers’ willingness to pay to invisibly, instantaneously reprice their goods, offering different prices to each customer.
The Intercept publishes a previously-unseen set of Snowden docs detailing more than $500,000,000 worth of secret payments by the Japanese government to the NSA, in exchange for access to the NSA’s specialized surveillance capabilities, in likely contravention of Japanese privacy law (the secrecy of the program means that the legality was never debated, so no […]
Bamboo has lots of uses beyond just being panda food. Things like bikes, roads, scaffolding, and musical instruments are made from the fast-growing grass. But unless you are participating in a tropical-themed LARP, you probably wouldn’t want a shirt made from bamboo stalks. So why do bamboo bed sheets make any sense? Because yarn extracted from […]
If you want to work in tech, but don’t have any desire to code web apps to help businesses sell things to other business, you might want to consider a career in cybersecurity. Judging from the apparent complete infiltration of Russian hackers in American cyberspace, it seems fair to speculate that there’s a major shortage of […]
All moms are different. But all moms like getting flowers on Mother’s Day, and that’s a fact (not, however a fact we can document in any fashion.) Instead of getting chewed out for forgetting to call her on the second Sunday of May, you can take care of it ahead of time with Teleflora’s flower […]